Skip to main content
SP5007,785.76-0.17%DOW53,732.41-0.20%NASDAQ26,729.16-0.28%BTC$62,945.00-0.85%ETH$1,880.32-0.35%GOLD$4,432.00+0.26%OIL$82.40+1.42%
Smart Investors Daily
Sign InSign Up Free
AN

OTC · ANPCY

CelLBxHealth plc

Healthcare · Medical - Diagnostics & Research

$0.07

Up+$0.00 (+0.00%)

Updated Aug 15, 2026, 8:21 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
21.98M
P/E ratio
-0.22
Dividend yield
0.00%
52-week range
— – —
Volume
20.02K
Avg. volume
19.15K

Price performance

ANPCY price history

1M range · 0 trading sessions · Daily adjusted prices

ANPCY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest ANPCY news

The latest Smart Investors Daily articles mentioning ANPCY.

Stock researchCompany · Overview

ANPCY research

Overview

Company profile and research snapshot.

Company profile

ANGLE PLC S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$2.54
Implied upside
—
Analysts
10
Open full forecast

News briefing

No generated briefing is available yet.

proactiveinvestors.co.uk · Dec 2, 2025

CellbxHealth raises just shy of £1m in retail offer

CelLBxHealth PLC (AIM:CLBX, OTCQB:ANPCF) has wrapped up its latest retail fundraise, bringing in about £960,000 as part of a wider financing package designed to support the diagnostics company's plans to scale. The AIM-quoted group, which focuses on analysing circulating tumour cells, cancer cells that break away from a tumour and enter the bloodstream, said the retail offer launched last week is now closed.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By